Jesse J Geiger Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months, 3 weeks ago
Jesse J Geiger has an estimated net worth of at least $25.7 million*, as of March 5, 2025. They own 36,503 shares of MEDP stock. They have sold 83,680 shares of MEDP stock since 2021, for an estimated $13.7 million.
Jesse J Geiger $MEDP SEC Form 4 Insider Trading
Jesse J Geiger has filed a total of 5 insider trades in $MEDP since 2021. Their most recent trade was a sale of 41,801 shares, made on Jul 24, 2025. Their largest trade was a sale of 41,801 shares, made on Jul 24, 2025. We estimate that they now own 36,503 shares of $MEDP, worth an estimated $12.0 million.
Insider Trading at $MEDP
There have been a total of 273 insider trades reported at $MEDP since 2021, with 2.0 million shares purchased and 5.2 million shares sold. The most active insider traders in $MEDP stock have been August J. Troendle, August J. Troendle, and Stephen P Ewald. The most recent trade was a sale of 41,801 shares reported by JESSE J GEIGER (President), made on Jul 24, 2025.
History of Insider Stock Trades by Jesse J Geiger
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 41,801 | Jul 24, 2025 | July 28, 2025, 5:37 p.m. |
![]() |
Sale | 22,321 | Mar 04, 2024 | March 6, 2024, 5:42 p.m. |
![]() |
Sale | 2,558 | Feb 29, 2024 | March 1, 2024, 5:25 p.m. |
![]() |
Sale | 7,000 | Nov 15, 2022 | Nov. 17, 2022, 5:20 p.m. |
![]() |
Sale | 10,000 | Oct 26, 2021 | Oct. 27, 2021, 8 p.m. |
$MEDP Executives and Stock Owners with Insider Trades
-
August J. Troendle, CEO
-
August J. Troendle, President & CEO
-
Stephen P Ewald, General Counsel & Corp. Secy.
-
Jesse J Geiger, President
-
Kevin M. Brady, CFO & Treasurer
-
Susan E Burwig, Exec. VP, Operations
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.